Request a copy

Full Text

• Chast F, Chastel C, Elion G, Postel-Vinay N, Tilles G. Herpès et virus: deux mots millénaires. In: Virus herpès et pensée médicale, de l'empirisme au prix Nobel. Paris: Imothep-Maloine, 1997: 15-8.
• Mahy B. A dictionary of virology. 3e edition. London: Academic Press, 2001-95: 405.
• Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 1988; 10: S274-6.
• Enquist LW, Husak PJ, Banfield BW, Smith GA. Infection and spread of alphaherpesviruses in the nervous system. Adv Virus Res 1998; 51: 237-47.
• Berthommé H, Thomas J, Epstein AL. Vecteurs neurotropes atténués et défectifs dérivés du virus de l'herpès simplex de type 1 (HSV 1). Virologie 2001; 5: 131-45.
• Bartha A. Experimental reduction of virulence of Aujeszky's disease virus in Hungarian. Magyar Allatorvosok Lapja 1961; 16: 42-5.
• Kaashoek MJ, Straver PH, Van RE, Quak J, Van Oirschot JT. Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects. Vet Rec 1996; 139: 416-21.
• Bower JR, Mao H, Durishin C, et al. Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness. J Virol 1993; 73: 3843-53.
• Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, Arvin AM, Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 1998; 72: 965-74.
• Moffat JF, Zerboni L, Sommer MH, et al. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc Natl Acad Sci USA 1998; 95: 11969-74.
• Moffat JF, Ito H, Sommer M, Taylor S, Arvin AM. Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells. J Virol 2002; 76: 8468-71.
• Campadelli-Fiume G, Cocchi F, Menotti L, Lopez M. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol 2000; 10: 305-19.
• Kaashoek MJ, Rijsewijk FA, Ruuls RC, et al. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene. Vaccine 1998; 16: 802-09.
• Mettenleiter TC. Initiation and spread of alphaherpesvirus infections. Trends Microbiol 1994; 2: 2-4.
• Van Drunen Little-Van Den Hurk S, Khattar S, Tikoo SK, et al. Glycoprotein H (gII/gp108) and glycoprotein L form a functional complex which plays a role in penetration, but not in attachment, of bovine herpesvirus 1. J Gen Virol 1996; 77: 1515-20.
• Meyer G, Hanon E, Georlette D, Pastoret PP, Thiry E. Bovine herpesvirus type 1 glycoprotein H is essential for penetration and propagation in cell culture. J Gen Virol 1998; 79: 1983-7.
• Ye GJ, Vaughan KT, Vallee RB, Roizman B. The herpes simplex virus 1 UL34 protein interacts with a cytoplasmic dynein intermediate chain and targets nuclear membrane. J Virol 2000; 74: 1355-63.
• Heeg U, Dienes HP, Muller S, Falke D. Involvement of actin-containing microfilaments in HSV-induced cytopathology and the influence of inhibitors of glycosylation. Arch Virol 1986; 91: 907-13.
• Dienes HP, Knoblich A, Falke D. Loss of surface fibronectin after infection of cultured cells by HSV-1 and 2. Arch Virol 1985; 86: 223-37.
• Fenwick ML, Walker MJ. Suppression of the cellular macromolecules by herpes simplex virus. J Gen Virol 1978; 41: 37-51.
• Kwong AD, Frenkel N. Herpes simplex virus-infected cells contain a function(s) that destabilizes both host and viral mRNAs. Proc Natl Acad Sci USA 1987; 84: 1926-30.
• Hardy WR, Sandri-Goldin RM. Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J Virol 1994; 68: 7790-9.
• Feng X, Thompson YG, Lewis JB, Caughman GB. Expression and function of the equine herpesvirus 1 virion-associated host shutoff homolog. J Virol 1996; 70: 8710-8.
• Berthommé H, Jacquemont B, Epstein A. The pseudorabies virus host-shutoff homolog gene: nucleotide sequence and comparison with alphaherpesvirus protein counterparts. Virology 1993; 193: 1028-32.
• Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986; 67: 1759-816.
• Hinkley S, Ambagala AP, Jones CJ, Srikumaran S. A vhs-like activity of bovine herpesvirus-1. Arch Virol 2000; 145: 2027-46.
• Johnson PA, Miyanohara A, Levine F, Cahill T, Friedmann T. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J Virol 1992; 66: 2952-65.
• Debiasi RL, Kleinschmidt-Demasters BK, Richardson-Burns S, Tyler KL. Central nervous system apoptosis in human herpes simplex virus and cytomegalovirus encephalitis. J Infect Dis 2002; 186: 1547-57.
• Sadzot-Delvaux C, Thonard P, Schoonbroodt S, Piette J, Rentier B. Varicella-zoster virus induces apoptosis in cell culture. J Gen Virol 1995; 76: 2875-9.
• Hanon E, Vanderplasschen A, Lyaku J, Keil G, Denis M, Pastoret PP. Inactivated bovine herpesvirus 1 induces apoptotic cell death of mitogen-stimulated bovine peripheral blood mononuclear cells. J Virol 1996; 70: 4116-20.
• Hanon E, Meyer G, Vanderplasschen A, Dessy-Doize C, Thiry E, Pastoret PP. Attachment but not penetration of bovine herpesvirus 1 is necessary to induce apoptosis in target cells. J Virol 1998; 72: 7638-41.
• Hanon E, Keil G, Van Drunen Littel-Van Den Hurk S, et al. Bovine herpesvirus 1-induced apoptotic cell death: role of glycoprotein D. Virology 1999; 25: 191-7.
• Leopardi R, Roizman B. The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc Natl Acad Sci USA 1996; 93: 9583-7.
• Aubert M, O'Toole J, Blaho JA. Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J Virol 1999; 73: 10359-70.
• Munger J, Roizman B. The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc Natl Acad Sci USA 2001; 98: 10410-5.
• Dingwell KS, Brunetti CR, Hendricks RL, et al. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol 1993; 68: 834-45.
• Turner A, Bruun B, Minson T, Browne H. Glycoproteins gB, gD, and gH/gL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J Virol 1998; 72: 873-5.
• Johnson DC, Webb M, Wisner TW, Brunetti C. Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread. J Virol 2001; 75: 821-33.
• Santos RA, Hatfield CC, Cole NL, et al. Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology 2000; 275: 306-17.
• Demmin GL, Clase AC, Randall JA, Enquist LW, Banfield BW. Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibit cell-to-cell spread of virus infection. J Virol 2001; 75: 10856-69.
• Nakamichi K, Matsumoto Y, Otsuka H. Bovine herpesvirus 1 glycoprotein G is necessary for maintaining cell-to-cell junctional adherence among infected cells. Virology 2002; 294: 22-30.
• Kohl S. Herpes simplex virus. In: Feigin RD, Cherry JD, Eds. Textbook of pediatric infections disease. 4th edition. Philadelphia: Saunders, 1703-1731.
• Meyer G, Lemaire M, Ros C, et al. Comparative pathogenesis of acute and latent infections of calves with bovine herpesvirus type 1 and 5. Arch Virol 2001; 146: 633-52.
• Roels S, Charlier G, Letellier C, et al. Natural case of bovine herpesvirus 1 meningoencephalitis in an adult cow. Vet Rec 2000; 146: 586-8.
• Zuckermann FA. Aujeszky's disease virus: opportunities and challenges. Vet Res 2000; 31: 121-31.
• Kritas SK, Nauwynck HJ, Pensaert MB. Disssemination of wild-type and gC-, gE-, and gI-deleted mutants of Aujeszky's disease virus in the maxillary nerve and trigeminal ganglion of pigs after intranasal inoculation. J Gen Virol 1995; 76: 2063-6.
• Enquist LW, Tomishima MJ, Gross S, Smith GA. Directional spread of an alphaherpesvirus in the nervous system. Adv virus res 2002; 86: 5-16.
• Dingwell KS, Doering LC, Johnson DC. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J Virol 1995; 69: 7087-98.
• Kenneth MI, Stevens JG. Molecular and biological characterization of a Herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene. J Exp Med 1990; 172: 487-96.
• Geerts V, Beyer J, Lomniczi B, Mettenleiter TC. Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence. J Virol 2000; 74: 817-27.
• Chowdhury SI, Onderci M, Bhattacharjee PS, Al-Mubarak A, Weiss ML, Zhou Y. Bovine herpesvirus 5 (BHV-5) US9 is essential for BHV-5 neuropathogenesis. J Virol 2000; 76: 3839-51.
• Weber PC, Levine M, Glorioso JC. Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science 1987; 236: 576-9.
• Meignier B, Longnecker R, Mavromara-Nazos P, Sears AE, Roizman B. Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. Virology 1988; 162: 251-4.
• Moyal M, Berkowitz C, Rosen-Wolff A, Darai G, Becker Y. Mutations in the UL53 gene of HSV-1 abolish virus neurovirulence to mice by the intracerebral route of infection. Virus Res 1992; 26: 99-112.
• Rozenberg F, Lebon P. Analysis of herpes simplex virus type 1 glycoprotein D nucleotide sequence in human herpes simplex encephalitis. J Neurovirol 1996; 2: 289-95.
• Ferrari M, Mettenleiter TC, Romanelli MG, et al. A comparative study of pseudorabies virus (PRV) strains with defects in thymidine kinase and glycoprotein genes. J Comp Pathol 2000; 123: 152-63.
• Kaashoek MJ, Van Engelenburg FA, Moerman A, et al. Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants. Vet Microb 1996; 48: 143-53.
• Whetstone CA, Miller JM, Seal BS, Bello LJ, Lawrence WC. Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant. Arch Virol 1992; 122: 207-14.
• Roizman B, Knipe MD. Herpes simplex virus and their replication. In: Fields, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. Virology. 4th edition. Philadelphia: Lippincott Williams et Wilkins, 2000: 2399-459.
• Gielkens AL, Peeters BP. Function of Aujeszky's disease virus proteins in virus replication and virulence. Acta Vet Hung 1994; 42: 227-41.
• De Wind N, Berns A, Gielkens A, Kimman T. Ribonucleotide reductase-deficient mutants of pseudorabies virus are avirulent for pigs and induce partial protective immunity. J Gen Virol 1993; 74: 351-9.
• Liang X, Chow B, Babiuk LA. Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle. Vaccine 1997; 15: 1057-64.
• Denis M, Splitter G, Thiry E, Pastoret PP, Babiuk LA. Infectious bovine rhinotracheitis (bovine herpesvirus 1): helper T cells, cytotoxic T cells and NK cells. In: Goddeeris BM, Morrison WI. Cell-mediated immunity in ruminants. Boca Raton: CRC Press, 1994: 157-72.
• Mossman KL, Smiley JR. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J Virol 2002; 76: 1995-98.
• Cassady KA, Gross M, Roizman B. The herpes simplex virus US11 protein effectively compensates for the gammal (34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. J Virol 1998; 72: 8620-6.
• Abendroth A, Slobedman B, Lee E, Mellins E, Wallace M, Arvin AM. Modulation of major histocompatibility class II protein expression by varicella-zoster virus. J Virol 2000; 74: 1900-7.
• Friedman HM, Cohen GH, Eisenberg RJ, Seidel CA, Cines DB. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 1984; 309: 633-5.
• Hung SL, Peng C, Kostavasili I, et al. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology 1994; 203: 299-312.
• Bryant NA, Davis-Pointer N, Vanderplasschen A, Alcami A. Glycoprotein G from alphaherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J 2003; 22: 833-46.
• Nagashunmugam T, Lubinski J, Wang L, et al. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobuline G Fc receptor. J Virol 1998; 72: 5351-9.
• Favoreel HW, Nauwynck HJ, Halewyck HM, Van Oosveldt P, Mettenleiter TC, Pensaert MB. Antibody-induced endocytosis of viral glycoproteins and major histocompatibility complex class I on pseudorabies virus-infected monocytes. J Gen Virol 1999; 80: 1283-91.
• York IA, Roop C, Andrews DW, Riddell SR, Graham FL, Johnson DC. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8 +T lymphocytes. Cell 1994; 77: 525-35.
• Goldsmith K, Chen W, Johnson DC, Hendricks RL. Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8 +T cell response. J Exp Med 1998; 187: 341-8.
• Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin AM. Varicellazoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol 2001; 75: 4878-88.
• Warren LM, Babiuk LA, Campos M. Effects of BHV-1 on PMN adhesion to bovine lung endothelial cells. Vet Immunol Immunopathol 1996; 55: 73-82.
• Griebel PJ, Ohmann HB, Lawman MJ, Babiuk LA. The interaction between bovine herpesvirus type 1 and activated bovine T lymphocytes. J Gen Virol 1990; 71: 369-77.
• Winkler MT, Doster A, Jones C. Bovine herpesvirus 1 can infect CD4 + lymphocytes and induce programmed cell death during acute inection of cattle. J Virol 1999; 73: 8657-68.
• Deshmane SL, Fraser NW. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J Virol 1989; 63: 943-7.
• Sadzot-Delvaux C, Arvin AM, Rentier B. Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity. J Infect Dis 1998; 178: S43-7.
• Dobson AT, Sederati F, Devi-Rao G, et al. Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J Virol 1989; 63: 3844-51.
• Hossain A, Schang LM, Jones C. Identification of gene products encoded by the latency-related gene of bovine herpesvirus 1. J Virol 1995; 69: 5345-52.
• Sawtell NM, Thompson RL. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J Virol 1992; 66: 2157-69.
• Thompson RL, Sawtell NM. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J Virol 1997; 71: 5432-40.
• Mador N, Goldenberg D, Cohen O, Panet A, Steiner I. Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line. J Virol 1998; 72: 5067-75.
• Ciacci-Zanella J, Stone M, Henderson G, Jones C. The latency-related gene of bovine herpesvirus 1 inhibits programmed cell death. J Virol 1999; 73: 9734-40.
• Thompson RL, Sawtell NM. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J Virol 2001; 75: 6660-75.
• Inman M, Lovato L, Doster A, Jones C. A mutation in the latency-related gene of bovine herpesvirus 1 disrupts the latency reactivation cycle in calves. J Virol 2002; 76: 6771-9.
• Perng GC, Slanina SM, Yukht A, et al. A herpes simplex virus type 1 latency-associated transcript mutant with increased virulence and reduced spontaneous reactivation. J Virol 1999; 73: 920-9.
• Lemaire M, Meyer G, Baranowski E, et al. Production of bovine herpesvirus type 1-seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves. J Clin Microbiol 2000; 38: 4233-8.
• Picard O. Herpetic infections and human immunodeficiency virus. Pathol Biol 2002; 50: 460-2.